The Hemodynamic Effects of Aortic Regurgitation in Patients Supported by a HeartMate 3 Left Ventricular Assist Device
Authors:
- 23 August 2023
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 30 (1) , 95-99
Abstract
No abstract availableFunding Information
- National Institutes of Health (HL146964, K23 HL148528)
- Abbott Laboratories
- Boston Scientific Corporation
This publication has 10 references indexed in Scilit:
- The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year UpdateThe Journal of Heart and Lung Transplantation, 2023
- Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized TrialJAMA, 2022
- Development of De Novo Aortic Insufficiency in Patients With HeartMate 3The Annals of Thoracic Surgery, 2022
- Impact of worsening of aortic insufficiency during HeartMate 3 LVAD supportArtificial Organs, 2020
- Aortic Insufficiency and Hemocompatibility-related Adverse Events in Patients with Left Ventricular Assist DevicesJournal of Cardiac Failure, 2019
- Aortic Insufficiency During Contemporary Left Ventricular Assist Device SupportJACC: Heart Failure, 2018
- The Hemodynamic Effects of Aortic Insufficiency in Patients Supported With Continuous-Flow Left Ventricular Assist DevicesJournal of Cardiac Failure, 2017
- Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVADJACC: Cardiovascular Imaging, 2016
- Hemodynamic Ramp Tests in Patients With Left Ventricular Assist DevicesJACC: Heart Failure, 2016
- Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device RecipientsCirculation: Heart Failure, 2014